The novel immunoregulatory molecule FGL2: A potential biomarker for severity of chronic hepatitis C virus infection

Journal of Hepatology

Volumn 53, Issue 4, 2010, Pages 608-615

  Foerster, Katharina ^a   Helmy, Ahmed ^a   Zhu, Yi ^a   Khattar, Ramzi ^a   Adeyi, Oyedele A ^b   Wong, Kit Man ^a   Shalev, Itay ^a   Clark, David A ^a,d   Wong, Pui Yuen ^b   Heathcote, Elizabeth J ^c   Phillips, Melville J ^b   Grant, David R ^a   Renner, Eberhard L ^a   Levy, Gary A ^a   Selzner, Nazia ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

FGL2; HCV; Treg cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; FIBRINOGEN; FIBRINOGEN LIKE PROTEIN 2; PEGINTERFERON ALPHA2B; RIBAVIRIN; SERUM ALBUMIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; DISEASE MARKER; DISEASE SEVERITY; DRUG DOSE COMPARISON; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LIVER BIOPSY; LIVER FIBROSIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTHROMBIN TIME; REGULATORY T LYMPHOCYTE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FIBRINOGEN; HEPATITIS C, CHRONIC; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 77956265027     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.04.020     Document Type: Article

References (28)

1. R.F. Doolittle The structure and evolution of vertebrate fibrinogen Ann NY Acad Sci 408 1983 13 27
2. G.A. Levy, J.L. Leibowitz, and T.S. Edgington Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice J Exp Med 154 1981 1150 1163
3. + regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis Hepatology 49 2009 387 397
4. G.A. Levy, M. Liu, and J. Ding Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis Am J Pathol 156 2000 1217 1225
5. P.A. Marsden, Q. Ning, and L.S. Fung The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis J Clin Invest 112 2003 58 66
6. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion J Exp Med 199 2004 1479 1489
7. J.D. Fontenot, J.P. Rasmussen, and M.A. Gavin A function for interleukin 2 in Foxp3-expressing regulatory T cells Nat Immunol 6 2005 1142 1151
8. L.M. Williams, and A.Y. Rudensky Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 Nat Immunol 8 2007 277 284
9. S. Marazzi, S. Blum, and R. Hartmann Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes J Immunol 161 1998 138 147
10. C.W. Chan, L.S. Kay, and R.G. Khadaroo Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells J Immunol 170 2003 4036 4044
11. I. Shalev, H. Liu, and C. Koscik Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis J Immunol 180 2008 249 260
12. + T regulatory cell-mediated suppression Immunity 30 2009 636 645
13. J.N. Stoop, R.G. van der Molen, and C.C. Baan Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection Hepatology 41 2005 771 778
14. + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B J Immunol 177 2006 739 747
15. + T cells during chronic hepatitis C virus infection J Virol 79 2005 7860 7867
16. + T cells during persistent hepatitis C virus infection J Virol 79 2005 7852 7859
17. R. Cabrera, Z. Tu, and Y. Xu An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection Hepatology 40 2004 1062 1071
18. + T cell response primed by DNA immunization World J Gastroenterol 11 2005 3772 3777
19. H. Liu, I. Shalev, and J. Manuel The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression Eur J Immunol 38 2008 3114 3126
20. E. Engvall, and P. Perlmann Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G Immunochemistry 8 1971 871 874
21. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289
22. + regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 2005 345 352
23. Y. Belkaid, and B.T. Rouse Natural regulatory T cells in infectious disease Nat Immunol 6 2005 353 360
24. S.E. Allan, G.X. Song-Zhao, and T. Abraham Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3 Eur J Immunol 38 2008 3282 3289
25. T.L. Denning, S.W. Granger, and D. Mucida Mouse TCRalphabeta + CD8alphaalpha intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses J Immunol 178 2007 4230 4239
26. + NKT-like cells Genome Biol 9 2008 R119.1 R119.18
27. D. Valmori, A. Merlo, and N.E. Souleimanian A peripheral circulating compartment of natural naive CD4 Tregs J Clin Invest 115 2005 1953 1962
28. + regulatory T cells in human thymus and periphery Immunity 27 2008 870 880